The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2017 | Genetic risks in CLL
Claire Dearden, MBBS, MD, FRCP, FRCPath from the Royal Marsden Hospital, London, UK, discusses familial risk in CLL at the 2017 British Society for Haematology (BSH) Annual Scientific Meeting in Brighton, UK. Currently, there are 20 known genes involved B cell development, that if inherited, increase susceptibility to CLL. This research is not at a point where these genes can be used to predict CLL. These genes, however, are used as risk factors. Individuals who have a family member with CLL are 8 times more likely to develop the disease themselves. This video has been supported by Napp Pharmaceuticals Ltd through an unrestricted educational grant to Magdalen Medical Publishing.
